CMS will cover DNA sequencing for Medicare cancer patients

The CMS will now cover diagnostic laboratory tests using gene sequencing technology for Medicare cancer patients. The agency said the tests can help patients and their oncologists make better treatment decisions.

from Modern Healthcare Breaking News

If You Enjoyed This, Take 5 Seconds To Share It

• 
• 
• 
• 
• 
•